ACELRX PHARMACEUTICALS INC's ticker is ACRX and the CUSIP is 00444T100. A total of 60 filers reported holding ACELRX PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $166,000 | -11.2% | 794,164 | +3.5% | 0.12% | -10.5% |
| Q2 2022 | $187,000 | +2.2% | 767,154 | +19.4% | 0.13% | +14.7% |
| Q1 2022 | $183,000 | -37.1% | 642,515 | +23.7% | 0.12% | -32.6% |
| Q4 2021 | $291,000 | -41.1% | 519,274 | +7.3% | 0.17% | -46.2% |
| Q3 2021 | $494,000 | -21.8% | 483,925 | +5.7% | 0.32% | -25.4% |
| Q2 2021 | $632,000 | -20.4% | 457,959 | -2.0% | 0.43% | -26.8% |
| Q1 2021 | $794,000 | +40.3% | 467,150 | +2.4% | 0.59% | +29.9% |
| Q4 2020 | $566,000 | -15.1% | 456,090 | -2.9% | 0.45% | -26.4% |
| Q3 2020 | $667,000 | +31.8% | 469,703 | +12.4% | 0.61% | +22.4% |
| Q2 2020 | $506,000 | +0.9% | 417,804 | -1.7% | 0.50% | -16.8% |
| Q1 2020 | $501,636 | -5.0% | 425,115 | +70.0% | 0.60% | +18.0% |
| Q4 2019 | $528,000 | – | 250,110 | – | 0.51% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 6,574,060 | $27,874,000 | 1.68% |
| SENZAR ASSET MANAGEMENT, LLC | 798,381 | $3,385,000 | 0.58% |
| Cormorant Asset Management, LP | 850,000 | $3,604,000 | 0.48% |
| Palo Alto Investors LP | 2,135,739 | $9,056,000 | 0.40% |
| Opus Point Partners Management, LLC | 99,959 | $424,000 | 0.34% |
| Granahan Investment Management | 1,582,237 | $6,709,000 | 0.19% |
| Joel Isaacson & Co., LLC | 70,660 | $300,000 | 0.08% |
| MARINER INVESTMENT GROUP LLC | 59,700 | $253,000 | 0.06% |
| MYCIO WEALTH PARTNERS, LLC | 75,000 | $318,000 | 0.06% |
| Cornerstone Capital, Inc. | 59,200 | $251,000 | 0.06% |